Ifosfamide (Compound)

Synonyms:ifosfamide, Isophosphamide, 3778-73-2, Iphosphamide, Isofosfamide, Ifex, Ifosfamid, Mitoxana, Iphosphamid, Isoendoxan, Naxamide, I-Phosphamide, Holoxan, Cyfos, Ifsofamide, Holoxan 1000, ASTA Z 4942, MJF 9325, Ifosfamida, Ifosfamidum, MJF-9325, isosfamide, NSC-109724, NCI-C01638, Z4942, Z-4942, ifomide, NSC 109724, A 4942, Z 4942, 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide, NSC109724, 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide, N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide, N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide, N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide, ISOCYCLOPHOSPHAMIDE, UM20QQM95Y, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide, CHEBI:5864, Ifosphamide, DTXSID7020760, 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide, 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide, 3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxaazaphosphorin 2-oxide, N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide, NCGC00016639-01, CAS-3778-73-2, Ifosfamide Sterile, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide, Ifosfamidum [INN-Latin], Ifosfamida [INN-Spanish], DTXCID90760, (R)-Ifosfamide, (S)-Ifosfamide, 66849-34-1, (R)-3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2lambda5-oxazaphosphinan-2-one, (2-CHLORO-ETHYL)-[(R)-3-(2-CHLORO-ETHYL)-2-OXO-2LAMBDA5-[1,3,2]OXAZAPHOSPHINAN-2-YL]-AMINE, CCRIS 352, HSDB 7023, SR-05000002022, EINECS 223-237-3, IFEX (TN), UNII-UM20QQM95Y, BRN 0611835, Ifosfamide (JAN/USP/INN), N,3-bis(2-chloroethyl)-2-oxo-1,3,2?^{5}-oxazaphosphinan-2-amine, Ifosfamid A, 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorineoxide, Ifosfamide in bulk, 2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd, Isophosphamide,(S), N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide, N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide, MFCD00057374, 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide, N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German], Ifosfamide - Bio-X, Ifosfamide [USAN:USP:INN:BAN:JAN], starbld0001221, Ifosfamide, >=98%, IFOSFAMIDE [MI], IFOSFAMIDE [INN], IFOSFAMIDE [JAN], Prestwick0_000833, Prestwick1_000833, Prestwick2_000833, Prestwick3_000833, IFOSFAMIDE [HSDB], IFOSFAMIDE [USAN], Intermediate of Ifosfamide, IFOSFAMIDE [VANDF], N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid, IFOSFAMIDE [MART.], SCHEMBL4885, CHEMBL1024, IFOSFAMIDE [USP-RS], IFOSFAMIDE [WHO-DD], BSPBio_000785, ISOPHOSPHAMIDE [IARC], MLS002154021, Ifex (TN) (Bristol Meyers), SPBio_002706, BPBio1_000865, GTPL7201, IFOSFAMIDE [EP IMPURITY], IFOSFAMIDE [ORANGE BOOK], IFOSFAMIDE [EP MONOGRAPH], (S)-3-(2-chloroethyl)-2-((2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide, BDBM189358, HMS1570H07, HMS2090M12, HMS2093N07, HMS2097H07, HMS2232O10, HMS3374B08, HMS3654B15, HMS3714H07, IFOSFAMIDE [USP MONOGRAPH], Pharmakon1600-01505480, {3-(2-Chloroethyl)-2-[(2-, BCP06596, WLN: T6NPOTJ AM2G BO B2G, Tox21_110539, Tox21_201815, Tox21_302775, BBL028071, N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine, N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine, NSC759154, s1302, STL058690, AKOS005711213, N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide, Tox21_110539_1, AB02316, AC-2113, CCG-213464, CS-1424, DB01181, NSC-759154, N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine, Ifosfamide, analytical reference material, NCGC00179435-01, NCGC00179435-02, NCGC00179435-03, NCGC00179435-06, NCGC00179435-07, NCGC00256413-01, NCGC00259364-01, AS-10978, BI166243, HY-17419, NCI60_000233, SMR001233348, SBI-0206804.P001, DB-049196, AB00513932, FT-0603650, FT-0670282, I0713, SW197177-4, C07047, D00343, AB00513932-06, AB00513932-07, AB00513932-08, AB00513932_09, AB00513932_10, EN300-7476797, A823873, Q418560, Q-101874, SR-05000002022-1, SR-05000002022-3, SR-05000002022-5, BRD-A67097164-001-11-2, Ifosfamide, British Pharmacopoeia (BP) Reference Standard, Ifosfamide, European Pharmacopoeia (EP) Reference Standard, Ifosfamide, United States Pharmacopeia (USP) Reference Standard, 2,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxy-, 2,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd, N,3-bis(2-chloroethyl)-2-oxo-1,3,2$l;{5}-oxazaphosphinan-2-amine, {3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,} 2-oxazaphosphorine oxide, 1,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide, 2H-1,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide, 2H-1,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide, 3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxazaphosphorin-2-one, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2$l^{5}-oxazaphosphinan-2-one, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,2-oxazaphosphorine oxide, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,2-oxazaphosphorineoxide, 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,2-oxazaphosphorine 2-oxide, N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphinan-2-amine 2-oxide #, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino][(perhydrochloroethyl)amino]perhydro-2h-1,3,2-oxazaphospho

Pubchem:PUBCHEM:3690

Id:4f64993b-e5c9-5ab7-b5d2-392b9abf450d

Description:nan